Katalin Karikó

25.8k citations
103 papers · 21.1k · 15 hit papers · h-index 51

Impact in

  • Immunology top 0.2%
    • Immunotherapy and Immune Responses
    • Immune Response and Inflammation
    • interferon and immune responses
    • SARS-CoV-2 and COVID-19 Research

Papers in

    • Immunotherapy and Immune Responses 12
    • interferon and immune responses 11
    • Immune Response and Inflammation 8
    • RNA Interference and Gene Delivery 34
    • RNA and protein synthesis mechanisms 10
    • DNA and Nucleic Acid Chemistry 8

Katalin Karikó

103 papers receiving 20.1k citations

Katalin Karikó's Hit Papers

Lyophilization provides long-term stability for a lipid nanoparticle-formulated, nucleoside-modified mRNA vaccine 2022 · 270 citations
2700+7+14Years since publication5001k1.5k2k

Peers

Katalin Karikó
Comparison fields: 5 of 153
  • Immunology 4.4k
  • Infectious Diseases 3.9k
  • Molecular Biology 10.5k
  • Virology 438
  • Ophthalmology 412
Replace Clifford V. Harding with:
Clifford V. Harding United States
Matthew L. Albert France
Olivier J Lantz France
Muzlifah A. Haniffa United Kingdom
Gosse J. Adema Netherlands
David T. Curiel United States
Gilla Kaplan United States
Michael B. Brenner United States
Gunther Hartmann Germany
Katalin Karikó relative to Clifford V. Harding United States Clifford V. Harding's profile →
Citations per field
00.5×2×4×6.0×
Clifford V. Harding · 1×
Citations per year

Countries citing papers authored by Katalin Karikó

Since Specialization
Citations

This map shows the geographic impact of Katalin Karikó's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Katalin Karikó with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Katalin Karikó more than expected).

Fields of papers citing papers by Katalin Karikó

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Katalin Karikó. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Katalin Karikó. The network helps show where Katalin Karikó may publish in the future.

Co-authors

The 25 scholars most cited alongside Katalin Karikó, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Katalin Karikó Line = papers co-authored together Katalin Karikó links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 103 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Suppression of RNA Recognition by Toll-like Receptors: The Impact of Nucleoside Modification and the Evolutionary Origin of RNA
Hit paper breakdown →
20052107
2
mRNA-based therapeutics — developing a new class of drugs
Hit paper breakdown →
20141977
3
COVID-19 vaccine BNT162b1 elicits human antibody and TH1 T cell responses
Hit paper breakdown →
20201585
4
Incorporation of Pseudouridine Into mRNA Yields Superior Nonimmunogenic Vector With Increased Translational Capacity and Biological Stability
Hit paper breakdown →
20081477
5
mRNA Is an Endogenous Ligand for Toll-like Receptor 3
Hit paper breakdown →
2004914
6
Expression kinetics of nucleoside-modified mRNA delivered in lipid nanoparticles to mice by various routes
Hit paper breakdown →
2015838
7
Sequence- and target-independent angiogenesis suppression by siRNA via TLR3
Hit paper breakdown →
2008779
8
Zika virus protection by a single low-dose nucleoside-modified mRNA vaccination
Hit paper breakdown →
2017744
9
BNT162b2 vaccine induces neutralizing antibodies and poly-specific T cells in humans
Hit paper breakdown →
2021738
10
Generating the optimal mRNA for therapy: HPLC purification eliminates immune activation and improves translation of nucleoside-modified, protein-encoding mRNA
Hit paper breakdown →
2011736
11
Lipid nanoparticles enhance the efficacy of mRNA and protein subunit vaccines by inducing robust T follicular helper cell and humoral responses
Hit paper breakdown →
2021592
12 2010545
13
DICER1 deficit induces Alu RNA toxicity in age-related macular degeneration
Hit paper breakdown →
2011526
14 2018434
15
A Facile Method for the Removal of dsRNA Contaminant from In Vitro-Transcribed mRNA
Hit paper breakdown →
2019423
16
A noninflammatory mRNA vaccine for treatment of experimental autoimmune encephalomyelitis
Hit paper breakdown →
2021399
17 2004380
18 2020304
19 2017303
20 2011271

About Katalin Karikó

Katalin Karikó is a scholar working on Immunology, Molecular Biology, Cancer Research, Virology and Neurology, having authored 103 papers that have together received 21.1k indexed citations. Recurring topics across this work include RNA Interference and Gene Delivery (34 papers), Immunotherapy and Immune Responses (12 papers), interferon and immune responses (11 papers), RNA and protein synthesis mechanisms (10 papers), DNA and Nucleic Acid Chemistry (8 papers), Immune Response and Inflammation (8 papers), Protease and Inhibitor Mechanisms (7 papers) and HIV Research and Treatment (5 papers). The work is most often cited by research in Immunology (4.4k citations), Infectious Diseases (3.9k citations), Molecular Biology (10.5k citations), Virology (438 citations) and Ophthalmology (412 citations). Katalin Karikó has collaborated with scholars based in United States, Germany and Hungary. Frequent co-authors include Drew Weissman, Hiromi Muramatsu, Uğur Şahin, Houping Ni, Özlem Türeci, Michael H. Buckstein, John Capodici, János Ludwig, Frank A. Welsh and Norbert Pardi. Their work appears in journals such as Molecular Therapy, Nature, The Journal of Immunology, Nucleic Acids Research and Biochemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact